Proteomics Products & Reviews

Odyssey One-Color Protein Molecular Weight Markers fluoresce in the 700nm channel of any of the Odyssey Imaging Systems and contain ten protein bands of 10, 15, 20, 25, 37, 50, 75, 100, 150, and 250 kDa, with molecular weight shifts of 5% and minimal band broadening.

LICORbio Western Blotting Kits provide a convenient way to purchase reagents and membranes that are optimized for infrared fluorescence detection on the Odyssey infrared imaging systems.

IRDye QC-1 is the first non-fluorescent (dark) quencher, compatible with a wide range of visible and near-infrared fluorophores (~500 – 800 nm).

The CellTag™ 700 Stain ICW (In-Cell Western™) Kits provide detection reagents for cell-based In-Cell Western Assays.

The Odyssey® Infrared EMSA Kit coupled with IRDye® 700 EMSA oligonucleotides is an excellent alternative method to radioisotopic and chemiluminescent detection methods for EMSA analysis and visualization. Using IRDye EMSA reagents, assays can be completed in less than two hours with no gel transfer or film exposure.

A DNA oligonucleotide end-labeled with IRDye 700 infrared dye is a good substrate for protein binding. Using the Odyssey Infrared Imaging System, IRDye infrared dye labeled DNA detection is linear within a 50-fold dilution range from 9.1 fmol to 0.18 fmol.

IRDye Labeling Kits come in 3 forms and allow you to label your own peptides, antibodies, or proteins.

The Odyssey XF is the perfect entry point for labs transitioning from qualitative chemiluminescent Western blotting to more robust quantitative data analysis. Drawing from more than 30 years of imaging expertise, the Odyssey XF offers unmatched dynamic range with the click of a mouse. In addition to two NIR lasers, it has LED and CCD capabilities, providing multi-functional versatility for greater value.

The CellTag™ 520 Stain ICW (In-Cell Western™) Kits provide detection reagents for cell-based In-Cell Western Assays.

Fast track precise spatial multiplexing

Automated Plate Washer

Recombinant or purified CA19-9 antigen, a sialylated Lewis blood group antigen, which is a widely used serum biomarker for pancreatic and gastrointestinal cancers.

High-purity proteins produced through genetic engineering in heterologous expression systems, ensuring consistency, scalability, and reduced lot-to-lot variability for research and development.

Recombinant Human Programmed Death-Ligand 1 (PD-L1/CD274/B7-H1), the primary ligand for PD-1, expressed on tumor and immune cells to suppress anti-tumor immunity.

Recombinant Human Bone Morphogenetic Protein 7 (BMP-7), a TGF-β superfamily member that induces bone and cartilage formation and plays roles in renal development and repair.

An extensive collection of recombinant Cluster of Differentiation (CD) proteins, which are key cell surface markers for immunophenotyping, immune function studies, and therapeutic targeting.

Recombinant Human Bone Morphogenetic Protein 2 (BMP-2), a key regulatory protein that induces bone and cartilage formation, used extensively in orthopedics and stem cell differentiation.

Recombinant Human Apolipoprotein E (ApoE), a key protein in lipid metabolism that plays a central role in cardiovascular health and Alzheimer's disease pathogenesis.

Recombinant Human B-cell lymphoma 2 (BCL-2) protein, a key regulator of apoptosis (programmed cell death) and a well-established oncoprotein in many cancers.

Recombinant Human B-cell Antigen Receptor Complex-associated protein alpha chain (CD79A), a essential component of the B-cell receptor (BCR) and a marker for B-cell lineage.

A focused set of recombinant immune regulatory proteins, such as PD-1, PD-L1, and CTLA-4, essential for research and drug discovery in cancer immunotherapy and autoimmunity.

Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.

A portfolio of recombinant immunoglobulins and cell surface proteins serving as critical targets for the development and functional validation of Chimeric Antigen Receptor T-cell (CAR-T) therapies.

Recombinant Human Fibroblast Growth Factor 2 (Basic FGF), a potent mitogen and morphogen for a wide range of mesoderm and neuroectoderm-derived cells in culture.

Recombinant Human Erythropoietin (EPO), the primary hormone regulating red blood cell production (erythropoiesis), used in research and as a therapeutic for anemia.